Journal Of Clinical oncology / CCR5 Safety, efficacy, and clinical outcomes of the anti-CCR5 inhibitor (Leronlimab) : A pooled analysis of three clinical trials in patients with mTNBC.

https://ascopubs.org/doi/abs/10.1200/JCO.2022...e&s=cl

Credit Bluemoon @ I Village